ESC Congress 2017 in Barcelona
2017; Lippincott Williams & Wilkins; Volume: 136; Issue: 17 Linguagem: Inglês
10.1161/circulationaha.117.031742
ISSN1524-4539
AutoresJeroen J. Bax, Stephan Achenbach,
Tópico(s)Cardiovascular Health and Risk Factors
ResumoHomeCirculationVol. 136, No. 17ESC Congress 2017 in Barcelona Free AccessNewsPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessNewsPDF/EPUBESC Congress 2017 in BarcelonaWhere the World of Cardiology Came Together Jeroen J. Bax, MD, PhD and Stephan Achenbach, MD Jeroen J. BaxJeroen J. Bax From Department of Cardiology, Leiden University Medical Center, The Netherlands (J.J.B.); and Department of Cardiology, Friedrich Alexander University, Erlangen-Nürnberg, Germany (S.A.). and Stephan AchenbachStephan Achenbach From Department of Cardiology, Leiden University Medical Center, The Netherlands (J.J.B.); and Department of Cardiology, Friedrich Alexander University, Erlangen-Nürnberg, Germany (S.A.). Originally published24 Oct 2017https://doi.org/10.1161/CIRCULATIONAHA.117.031742Circulation. 2017;136:1659–1661This summer brought cardiologists from all over the world to Barcelona, when the European Society of Cardiology (ESC) hosted ESC Congress 2017 in August 2017 (Figure 1). With 31 175 attendees from a record-breaking 153 countries and participants being able to choose from 780 sessions running in 28 parallel rooms, the 4.5-day event was 1 of the largest cardiovascular congresses ever. ESC's call for abstracts attracted >10 804 submissions, of which 4514 (42%) were selected for oral or poster presentation. Interestingly, the country from which the most abstracts were submitted—and accepted—was not in Europe. It was Japan, which has held first place in abstract submissions for the last 7 years. The United States, Korea, and China were also among the top 10 abstract submitting countries—a fact that highlights the increasingly global character of this conference.Download figureDownload PowerPointFigure 1. The ESC Congress 2017 was hosted in Barcelona, Spain in August 2017.For the educational component of ESC 2017 in Barcelona, >1574 faculty members from 74 countries had active roles. With ESC's efforts to increase the role of women in the program, a record 24% of invited presenters were female, up from 20% in previous years.As is typical, 3 areas of the ESC Congress attracted particular interest. There was the regularly featured Congress Spotlight, which in 2017—in line with the 40th anniversary of the first percutaneous coronary intervention performed by Andreas Grüntzig on September 16, 1977—was "40 years of PCI" [percutaneous coronary intervention] A dedicated Spotlight Stage was built and a series of live in the box sessions was created to showcase various aspects of interventional cardiology. The 40th anniversary of percutaneous coronary intervention was also featured on ESC TV, where, for example, cardiology luminaries who worked with Dr Grüntzig provided first-hand accounts of his contributions, his personality, and the spirit of innovation that marked the beginning of what is now a common procedure. In addition, a special percutaneous coronary intervention museum was created for the congress in collaboration with Euro-PCR.Another highlight of the congress—eagerly anticipated every year—is the presentation of new ESC Clinical Practice Guidelines. In this year´s edition, ESC 2017 hosted 4 new documents: guidelines on valvular heart disease, ST-elevation acute myocardial infarction, and peripheral arterial diseases, as well as a focused update on dual antiplatelet therapy. These guidelines were presented and discussed in numerous dedicated sessions, along with their clinical implementation and implications.Finally, Late Breaking trials and Hot Line sessions have become a major focus of attention for cardiovascular congresses; if novel and important, they will typically dominate the buzz in the hallways as well as media coverage around the event. This year's ESC Congress was certainly no exception, with a number of eagerly anticipated and high-impact trials presented and several making news headlines around the world. To name a few:COMPASS (Cardiovascular Outcomes for People Using Anticoagulation Strategies) demonstrated a beneficial effect of adding low-dose rivaroxaban to aspirin for the prevention of cardiovascular events in patients with coronary artery or peripheral arterial disease.CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study) provided proof-of-concept for residual inflammatory risk in otherwise well-controlled patients with prior myocardial infarction. The trial reported a 15% event reduction by treatment with canakinumab, an inhibitor of interleukin 1ß and interleukin 6. Although an increased rate of fatal infections was a trade-off, an unintended beneficial effect was a substantial reduction in the rate of fatal cancer, mainly driven by lung cancer.CASTLE-AF (Catheter Ablation Versus Standard Conventional Treatment in Patients With Left Ventricular Dysfunction and Atrial Fibrillation) demonstrated that ablation therapy in patients with atrial fibrillation and heart failure improves outcome.DETO2X-AMI (Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction) demonstrated that oxygen therapy has no effect on patients with acute coronary syndromes and oxygen saturations of ≥90%, highlighting that therapeutic concepts without substantial proof, even when deemed standard, do not necessarily afford benefit.LAACS (Left Atrial Appendage Closure During Open Heart Surgery), a randomized surgical trial, showed that routine ligation of the left atrial appendage in the context of open heart cardiac surgery significantly reduced the rate of perioperative ischemic events from 16% to 5%.The PURE registry (Prospective Urban and Rural Epidemiological Study) determined the effect of diet on mortality and cardiovascular events in 135 000 people. Among the presented results, 1 analysis showed no effect of fruit and vegetable consumption on cardiovascular disease (although there was a beneficial effect on overall mortality, albeit at lower consumption rates than previously expected—5 servings per day may not be necessary after all).It is important to note that ESC 2017 was a forum to honor individuals who have contributed prominently to the cardiovascular medicine field. Dr William Wijns (Galway, Ireland) and Dr Anthony DeMaria (San Diego, CA, United States) (Figure 2) received ESC gold medals, the highest honor that can be bestowed by the ESC. During the inaugural session, special recognition was also given to Dr Magdi Yacoub (London, United Kingdom) for his humanitarian work and to Dr Eric Topol (San Diego, CA, United States) who delivered a keynote address titled "The Future of Cardiovascular Medicine in the Digital Era."Download figureDownload PowerPointFigure 2. Professor A. DeMaria received the gold medal of the ESC.In fact, with digital health an area of ever-increasing importance, the ESC developed a Digital Health Area prominently placed in the center of the congress facility. This initiative hosted numerous hardware and software solutions to improve cardiovascular care, ranging from arrhythmia detection by smart devices to improved doctor-patient communication, each available to be experienced hands-on by delegates.It should be mentioned that ESC 2017 hosted an extensive digital presence. For several years running, the ESC 365 platform has allowed online access to all presentations at the ESC Congress, which means that all sessions at ESC 2017 have been archived and can be accessed around the world by virtually anyone interested (login but no membership is required). In 2017, this platform was complemented by expanded ESC TV programming, recorded live on the ESC TV stage. This programming featured lively discussions, interviews, summary sessions, and daily wrap-ups that provide condensed interpretation of what was new and particularly important. These videos are also accessible free of charge to anyone.On social media, the response to ESC 2017 was overwhelming. There were 306 million impressions for the #ESCCongress hashtag, which has been described as a record for a healthcare conference. More than 49 000 tweets came from 13 000 tweeters around the world.Overall, ESC Congress 2017 was perceived as particularly successful. Work has already begun for the next ESC Congress, to be held from August 25 to 29, 2018, in Munich, Germany.DisclosuresThe Department of Cardiology, Leiden University Medical Center, The Netherlands has received unrestricted research grants from Biotronik, Medtronic, Boston Scientific, and Edwards Lifesciences (Dr Bax).FootnotesCirculation is available at http://circ.ahajournals.org.Correspondence to: Jeroen J. Bax, Leiden University Medical Center, Albinusdreef 2, Leiden 2300 ZA, The Netherlands. E-mail [email protected] Previous Back to top Next FiguresReferencesRelatedDetailsCited By Hudson S and Mackenzie G (2018) 'Not your daughter's Facebook': Twitter use at the European Society of Cardiology Conference 2018, Heart, 10.1136/heartjnl-2018-314163, 105:2, (169-170), Online publication date: 1-Jan-2019. Gokcal E, Pasi M, Fisher M and Gurol M (2018) Atrial Fibrillation for the Neurologist: Preventing both Ischemic and Hemorrhagic Strokes, Current Neurology and Neuroscience Reports, 10.1007/s11910-018-0813-y, 18:2, Online publication date: 1-Feb-2018. October 24, 2017Vol 136, Issue 17 Advertisement Article InformationMetrics © 2017 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.117.031742PMID: 29061577 Originally publishedOctober 24, 2017 PDF download Advertisement
Referência(s)